期刊文献+

Adiponectin Gene Variation -4522C/T Is Associated with Type 2 Diabetic Obesity and Insulin Resistance in Chinese 被引量:2

脂联素基因单核苷酸多态性与Ⅱ型糖尿病合并肥胖及胰岛素抵抗相关联(英文)
下载PDF
导出
摘要 The authors investigated the possible association of -4522C/T variation of adiponectin gene with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Genotyping of SNP --4522C/T in 304 patients with CHD, 389 patients with T2DM, and 405 age and sex-matched healthy control subjects was carried out by means of PCR-RFLP approach. No significant difference in the genotype or allele frequencies was found, either between patients with CHD and control subjects, or between patients with T2DM and control subjects. However, in the subgroup analysis, an association of the TAr genotype and T allele with type 2 diabetes combined with obesity (BMI ≥ 25 kg/m2) was found (P = 0.014 and P = 0.034, respectively). Also the homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients with T/T genotype was significantly higher than that in T2DM patients carrying C allele (P = 0.0069). The authors' findings for the first time demonstrated that SNP --4522 in the adiponectin gene was associated with T2DM that combined with obesity and higher insulin resistance index in patients with T2DM. This indicated that the variation might associate with an increased susceptibility to type 2 diabetic obesity and insulin resistance. But -4522C/T polymorphism did not contribute to the susceptibility of CHD. 脂联素是近年新发现的脂肪组织特异性的细胞因子,其mRNA是脂肪组织中含量最丰富的基因转录产物,该因子可通过多种途径影响个体对胰岛素的敏感性。脂联素基因多态性与肥胖、胰岛素抵抗和2型糖尿病密切相关,而与冠心病相关性研究的报道较少。本研究以中国汉族人群1,098例为对象,其中304例冠心病(CHD)患者,389例糖尿病患者(T2DM),及405例性别年龄相匹配的正常对照,采用PCR-RFLP技术对脂联素基因-4522C/T进行基因分型,并分别对血脂水平、胰岛素抵抗、体重指数等临床数据进行分析比较。研究结果显示,脂联素基因-4522C/T各基因型及等位基因在CHD组与对照组、T2DM组与对照组中的分布差异无显著性;经分组分析发现,T2DM合并肥胖患者BMI≥25kg/m2TT基因型及T等位基因明显多于对照组,差异有显著性,P=0.014和P=0.034;TT基因型T2DM患者胰岛素抵抗指数(HOMA-IR)显著高于携带有C等位基因的T2DM患者,P=0.0069。本研究提示脂联素基因-4522C/T与中国汉族人群T2DM合并肥胖的发生及T2DM患者胰岛素抵抗相关,是引发糖尿病患者肥胖和胰岛素抵抗的重要候选基因,而与冠心病的发生无关联。
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 北大核心 2007年第10期877-884,共8页 遗传学报(英文版)
基金 the Chinese High Tech Programs (863) from the Ministry of Science and Technology (No. 2002BA- 711A08) the National Natural Science Foundation of China (No. 30671155, and 39993420) Grant FMU-RT002 of Program for Innovative Research Team in Science and Technology in Fujian Province University the Science Foundation from the Depart-ment of Education of Fujian Province (No. JA05251, and JB06215).
关键词 ADIPONECTIN single nucleotide polymorphism coronary heart disease type 2 diabetes insulin resistance 脂联素 单核苷酸多态性 冠心病 II型糖尿病 胰岛素抵抗
  • 相关文献

参考文献1

二级参考文献7

  • 1Maeda K, Okubo AK, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, APM1 (Adipose Most Abundant Gene Transcrip 1). Biochem Biophys Res Commun, 1996,221:286-289.
  • 2Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in Japanese population.Diabetes, 2002,51:536-540.
  • 3Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002,8:731-737.
  • 4Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of metabolic syndrome. PNAS, 2000,97:14478-14483.
  • 5Yamauchi T, Kamon J, Waki H, et al. Replenishment of the fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001,7:941-946.
  • 6陈名道.脂肪细胞产物与肥胖和代谢综合征[J].中华内分泌代谢杂志,2003,19(3):161-163. 被引量:92
  • 7洪洁,顾卫琼,张翼飞,唐金凤,杨颖,陈宇红,孙首悦,赵咏桔,宁光.胰岛素抵抗综合征患者血清脂联素和胰岛素敏感性的相关性研究[J].中华内分泌代谢杂志,2003,19(3):173-176. 被引量:93

共引文献38

同被引文献39

  • 1赵萸,骆天红,王侃侃,张济,郑培烝,赵春军,刘优萍,郑升,顾燕云,李果,罗敏.cDNA芯片研发及其在肥胖患者脂肪基因差异表达研究中的应用[J].生物化学与生物物理进展,2004,31(12):1067-1078. 被引量:3
  • 2李亚,张思仲,马用信,贺勇,董景涛,孙岩,何国平,张炜.ABCA1基因多态性与冠心病相关性研究[J].遗传,2005,27(4):549-552. 被引量:13
  • 3杜纪坤,黄青阳.脂蛋白脂酶基因的研究进展[J].遗传,2007,29(1):8-16. 被引量:33
  • 4李霞(摘译).儿童和成人肥胖的预测基因-FTO基因[J].中华医学信息导报,2007,22(11). 被引量:2
  • 5Marteau JB. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol, 2006, 7(2): 139-151.
  • 6Chaer RA, Billeh R, Massad MG. Genetics and gene manipulation therapy of premature coronary artery disease. Cardiology, 2004, 101(1-3): 122-130.
  • 7Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J Intern Med, 2002, 252(3): 247-254.
  • 8Punzalan FE, Sy RG, Santos RS, Cutiongco EM, Gosiengfiao S, Fadriguilan E, George P, Laurie A. Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. J Atheroscler Thromb, 2005,12(5): 276-283.
  • 9Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med,2007, 356(16): 1620-1630.
  • 10Deepak B. Diagnosis and screening for familial hyper-cholesterolaemia: finding the patients, finding the genes. Ann Clin Biochem, 2006,43(pt6): 441-456.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部